Maximizing cell therapy process flexibility and efficiency with next-generation technologies

Over the last two decades, the field of cancer treatment has undergone a revolution. Innovative cell therapies are offering new treatment options for many previously incurable diseases, including several types of blood cancers. Many patients who are ideal candidates for cell therapies may have exhausted every other treatment option or are facing disease recurrence. As such, they require rapid access to safe and efficacious treatments. One such innovative treatment is CAR-T cell therapy.